A subset of anti-PAD4 antibodies cross-reacts with the related enzyme PAD3 (termed anti-PAD3/4 antibodies) and have been associated with the most severe joint damage and imaging evidence of interstitial lung disease (ILD) [3]. Here, PADI4 is linked to interstitial lung disease.